IL6 and colorectal carcinoma: Additionally, miR-101-3p appears to target multiple transcripts that act synergistically to promote cell death and halt proliferation of CRC cells in vitro, by inhibiting Wnt and IL-6/JAK2/STAT3 signaling pathways.